1
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
Condition(s):Metastatic Breast Cancer; Advanced Breast CancerLast Updated:April 29, 2011Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast Cancer; Advanced Breast CancerLast Updated:April 29, 2011Terminated
Condition(s):Ovarian CancerLast Updated:July 19, 2012Completed
Condition(s):Malignant AscitesLast Updated:October 17, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.